WO2006042728A3 - Verwendung von ammoniumsalze der liponsäure zur behandlung diabetischer störungen - Google Patents
Verwendung von ammoniumsalze der liponsäure zur behandlung diabetischer störungen Download PDFInfo
- Publication number
- WO2006042728A3 WO2006042728A3 PCT/EP2005/011147 EP2005011147W WO2006042728A3 WO 2006042728 A3 WO2006042728 A3 WO 2006042728A3 EP 2005011147 W EP2005011147 W EP 2005011147W WO 2006042728 A3 WO2006042728 A3 WO 2006042728A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- salts
- disorders
- diabetic
- liponate
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004050353A DE102004050353A1 (de) | 2004-10-15 | 2004-10-15 | Verwendung stabiler Ammoniumsalze der Liponsäure zur Behandlung diabetischer und weiterer Störungen |
DE102004050353.2 | 2004-10-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006042728A2 WO2006042728A2 (de) | 2006-04-27 |
WO2006042728A3 true WO2006042728A3 (de) | 2007-03-22 |
Family
ID=35462236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/011147 WO2006042728A2 (de) | 2004-10-15 | 2005-10-17 | Verwendung von ammoniumsalze der liponsäure zur behandlung diabetischer störungen |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102004050353A1 (de) |
WO (1) | WO2006042728A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0615211A2 (pt) | 2005-08-17 | 2013-01-15 | Hills Pet Nutrition Inc | composiÇço, mÉtodo para evitar ou tratar doenÇa renal ou para a melhora da funÇço renal, kit, e, meio para comunicar informaÇço sobre ou instruÇÕes para a mistura e administraÇço de um ou mais das composiÇÕes, componentes de composiÇço, composiÇÕes alimentÍcias, ingredientes alimentÍcios e medicamentos renais e para uso dos dispositivos de diagnàstico renal |
WO2010056726A1 (en) * | 2008-11-11 | 2010-05-20 | Indigene Pharmaceuticals, Inc. | Compositions and methods for treating diabetes |
CN103830229A (zh) | 2008-12-30 | 2014-06-04 | 希尔氏宠物营养品公司 | 硫辛酸在治疗或预防陪伴动物的退行性关节病症、骨关节炎、软骨损伤,以及相关障碍中的应用 |
WO2010078319A1 (en) * | 2008-12-30 | 2010-07-08 | Hill's Pet Nutrition, Inc. | Lipoic acid containing compositions for use in the treatment and prevention of ki dney- related disorders in companion animals |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3288797A (en) * | 1963-08-20 | 1966-11-29 | Merck Ag E | Lipoic acid derivatives and their preparation |
FR1605097A (en) * | 1967-09-25 | 1973-01-12 | Stable alpha-lipoic acid | |
EP0572922A1 (de) * | 1992-06-05 | 1993-12-08 | ASTA Medica Aktiengesellschaft | Synergistische Kombination von Liponsäure und Vitaminen in Arzneimitteln |
US5281722A (en) * | 1991-11-16 | 1994-01-25 | Degussa Ag | Preparation and use of salts of the pure enantiomers of alpha-lipoic acid |
DE4331168A1 (de) * | 1993-09-14 | 1995-03-16 | Carl Heinrich Dr Weischer | Kombination von N-Acetyl-p-Aminophenol mit schwefelenthaltenden Carbonsäuren, wie z. B. alpha-Liponsäure und deren Derivate, zur Bekämpfung von Schmerzzuständen |
DE4344751A1 (de) * | 1993-12-28 | 1995-06-29 | Carl Heinrich Dr Weischer | Neue Vitamin B6-Derivate und deren Herstellung und Verwendung als Arzneimittel und als Kosmetika |
US6117899A (en) * | 1993-12-21 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as its sequelae |
WO2002036109A2 (en) * | 2000-11-02 | 2002-05-10 | University Of South Carolina | Use of pyridoxamine for the treatment and inhibition of obesity-related complications |
US6545039B1 (en) * | 1999-11-11 | 2003-04-08 | Viatris Gmbh & Co. Kg | Facilitated administration of α-lipoic acid or derivatives thereof |
WO2003047567A1 (de) * | 2001-12-03 | 2003-06-12 | Degussa Ag | STABILE, SAURE, WÄSSRIGE LÖSUNG ENTHALTEND α-LIPONSÄURE(-DERIVATE), VERFAHREN ZU DEREN HERSTELLUNG SOWIE IHRE VERWENDUNG |
WO2003049729A1 (de) * | 2001-12-08 | 2003-06-19 | Degussa Ag | Verwendung von kreatin und/oder kreatinderivate bei nicht krankheitsbedingten beeinträchtigungen und/oder störungen der muskelfunktion |
US6730686B1 (en) * | 1995-09-12 | 2004-05-04 | Kansas University Medical Center | Methods for inhibiting oxidative modification of proteins |
US6750209B1 (en) * | 1995-09-12 | 2004-06-15 | Kansas University Medical Center | Advanced glycation end-product intermediaries and post-amadori inhibition |
WO2004092157A1 (de) * | 2003-04-17 | 2004-10-28 | Basf Aktiengesellschaft | STABILE AMMONIUMSALZE DER α-LIPONSÄURE, IHRE HERSTELLUNG UND VERWENDUNG |
-
2004
- 2004-10-15 DE DE102004050353A patent/DE102004050353A1/de not_active Withdrawn
-
2005
- 2005-10-17 WO PCT/EP2005/011147 patent/WO2006042728A2/de active Application Filing
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3288797A (en) * | 1963-08-20 | 1966-11-29 | Merck Ag E | Lipoic acid derivatives and their preparation |
FR1605097A (en) * | 1967-09-25 | 1973-01-12 | Stable alpha-lipoic acid | |
US5281722A (en) * | 1991-11-16 | 1994-01-25 | Degussa Ag | Preparation and use of salts of the pure enantiomers of alpha-lipoic acid |
EP0572922A1 (de) * | 1992-06-05 | 1993-12-08 | ASTA Medica Aktiengesellschaft | Synergistische Kombination von Liponsäure und Vitaminen in Arzneimitteln |
DE4331168A1 (de) * | 1993-09-14 | 1995-03-16 | Carl Heinrich Dr Weischer | Kombination von N-Acetyl-p-Aminophenol mit schwefelenthaltenden Carbonsäuren, wie z. B. alpha-Liponsäure und deren Derivate, zur Bekämpfung von Schmerzzuständen |
US6117899A (en) * | 1993-12-21 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as its sequelae |
US6284787B1 (en) * | 1993-12-21 | 2001-09-04 | Asta Medica Aktiengesellschaft | Use of R-(+)-α-lipoic acid, R-(−)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae |
DE4344751A1 (de) * | 1993-12-28 | 1995-06-29 | Carl Heinrich Dr Weischer | Neue Vitamin B6-Derivate und deren Herstellung und Verwendung als Arzneimittel und als Kosmetika |
US6730686B1 (en) * | 1995-09-12 | 2004-05-04 | Kansas University Medical Center | Methods for inhibiting oxidative modification of proteins |
US6750209B1 (en) * | 1995-09-12 | 2004-06-15 | Kansas University Medical Center | Advanced glycation end-product intermediaries and post-amadori inhibition |
US6545039B1 (en) * | 1999-11-11 | 2003-04-08 | Viatris Gmbh & Co. Kg | Facilitated administration of α-lipoic acid or derivatives thereof |
WO2002036109A2 (en) * | 2000-11-02 | 2002-05-10 | University Of South Carolina | Use of pyridoxamine for the treatment and inhibition of obesity-related complications |
WO2003047567A1 (de) * | 2001-12-03 | 2003-06-12 | Degussa Ag | STABILE, SAURE, WÄSSRIGE LÖSUNG ENTHALTEND α-LIPONSÄURE(-DERIVATE), VERFAHREN ZU DEREN HERSTELLUNG SOWIE IHRE VERWENDUNG |
WO2003049729A1 (de) * | 2001-12-08 | 2003-06-19 | Degussa Ag | Verwendung von kreatin und/oder kreatinderivate bei nicht krankheitsbedingten beeinträchtigungen und/oder störungen der muskelfunktion |
WO2004092157A1 (de) * | 2003-04-17 | 2004-10-28 | Basf Aktiengesellschaft | STABILE AMMONIUMSALZE DER α-LIPONSÄURE, IHRE HERSTELLUNG UND VERWENDUNG |
Non-Patent Citations (1)
Title |
---|
ALDERSON N L ET AL: "AN AGE-INHIBITOR, PYRIDOXAMINE (PM), IS MORE EFFECTIVE THAN ANTIOXIDANTS OR ENALAPRIL (EP) IN PREVENTING NEPHROPATHY IN STZ-DIABETIC RATS", DIABETES, NEW YORK, NY, US, vol. 50, no. SUPPL 2, June 2001 (2001-06-01), pages A172,AN696 - P, XP009000054, ISSN: 0012-1797 * |
Also Published As
Publication number | Publication date |
---|---|
DE102004050353A1 (de) | 2006-04-20 |
WO2006042728A2 (de) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007022518A8 (en) | New uses of glucoregulatory proteins | |
WO2006113919A3 (en) | Aryl alkyl acid derivatives for and use thereof | |
WO2007006307A3 (en) | Novel salts of fumaric acid monoalkylesters and their pharmaceutical use | |
WO2005070390A3 (en) | Mitratapide oral solution | |
WO2008019395A3 (en) | Compounds for improving learning and memory | |
WO2007079199A3 (en) | Substituted bis-amide metalloprotease inhibitors | |
WO2008074840A3 (en) | Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders | |
WO2006113942A3 (en) | Method of inhibiting cathepsin activity | |
WO2007106469A3 (en) | Bicyclic carboxylic acid derivatives useful for treating metabolic disorders | |
WO2006127287A3 (en) | Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods | |
WO2005121078A3 (de) | Substituierte cyclopenten-verbindungen | |
WO2007019153A3 (en) | Methods for treating hypertension | |
WO2007016538A3 (en) | Preparation and use of biphenyl amino acid derivatives for the treatment of obesity | |
WO2006122186A3 (en) | 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia | |
WO2007120980A3 (en) | 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases | |
WO2003095398A3 (en) | Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same | |
WO2007014762A3 (en) | Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders | |
EP1604980A8 (de) | DPP-IV-Hemmer | |
WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
WO2006042728A3 (de) | Verwendung von ammoniumsalze der liponsäure zur behandlung diabetischer störungen | |
TW200719889A (en) | Amino acid derivatives | |
WO2007053499A3 (en) | Compounds useful as antagonists of ccr2 | |
WO2006121995A3 (en) | Methods for treating nephrolithiasis | |
WO2005112923A3 (en) | 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes | |
WO2006023586A3 (en) | Guanylhydrazone compounds, compositions, methods of making and using |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05795022 Country of ref document: EP Kind code of ref document: A2 |